ZYUS is a publicly traded Canadian-based life sciences company focused on the global development and commercialization of regulated cannabinoid-based pharmaceutical drug product candidates. Through clinical research, ZYUS is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, ZYUS is dedicated to delivering high quality, cGMP/EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The ZYUS vision is to reimagine the potential of pain therapeutics by pursuing regulatory approval of cannabinoid formulations and elevating cannabinoids as a standard of care in pursuit of transformational impact on patients’ lives. ZYUS: Advancing the Science of Well-Being.
View Top Employees from ZYUSWebsite | http://www.zyus.com |
Revenue | $16 million |
Employees | 48 (45 on RocketReach) |
Founded | 2018 |
Address | 204-407 Downey Rd, Saskatoon, Saskatchewan S7N 4L8, CA |
Phone | (306) 242-2357 |
Technologies |
JavaScript,
HTML,
Twitter
+20 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Life Science, Pharmaceutical |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular ZYUS employee's phone or email?
The ZYUS annual revenue was $16 million in 2024.
John Hiebert is the Director of Corporate Security of ZYUS.
45 people are employed at ZYUS.
ZYUS is based in Saskatoon, Saskatchewan.
The NAICS codes for ZYUS are [32541, 54, 32, 541, 325, 3254].
The SIC codes for ZYUS are [87, 873].